Sree Rayalaseema Hi-Strength Hypo Ltd

Sree Rayalaseema Hi-Strength Hypo's latest results show record revenue of ₹182.39 crores and a net profit increase of 3.93% quarter-on-quarter; however, year-on-year net profit declined by 7.94%, and operating margins have contracted, indicating challenges in profitability despite top-line growth.

Sr.Rayala.Hypo has experienced declining net sales and profits from Mar'23 to Mar'25, with net sales dropping from 1,650.12 Cr to 637.82 Cr and profit after tax decreasing from 154.25 Cr to 87.47 Cr, despite some stabilization in cash flow and asset growth. Total liabilities and assets both increased during this period, indicating a challenging financial environment.

Sr.Rayala.Hypo has experienced a significant decline in net sales and profits from Mar'23 to Mar'25, with net sales dropping from 1,650.12 Cr to 637.82 Cr. However, total assets increased, and net cash inflow improved during the same period.

Sree Rayalaseema Hi-Strength Hypo's latest results show a positive trend with net sales and profits at five-quarter highs, but a decline in the debtors turnover ratio indicates potential challenges in receivables collection. Overall, the performance is mixed, with strong sales and profitability but areas needing attention.

As of 07-Nov, Sree Rayalaseema Hi-Strength Hypo Ltd's stock price is 525.10, down 1.95% and underperforming with a year-to-date decline of 32.38%. The stock is trading below all key moving averages and has shown a significant drop in returns compared to the benchmark Sensex.

As of 15-Oct, Sree Rayalaseema Hi-Strength Hypo Ltd's stock price is declining at 563.05, down 0.32%, and has underperformed significantly over the past week, month, and year. It is trading below all key moving averages, with reduced investor participation indicated by a 59.61% drop in delivery volume.

As of October 14, 2025, Sr.Rayala.Hypo is considered an attractive investment due to its undervaluation compared to peers in the commodity chemicals industry, with a PE ratio of 9.98, significantly lower than competitors like Solar Industries and Gujarat Fluoroch, despite a recent stock decline of 34.32% compared to the Sensex.

As of October 1, 2025, the technical trend has shifted to a moderately strong bearish stance, supported by bearish MACD, moving averages, and Bollinger Bands, along with underperformance against the Sensex.

As of October 1, 2025, Sr.Rayala.Hypo has shifted to a bearish technical stance, supported by bearish MACD, moving averages, and Bollinger Bands, indicating a negative outlook in the near term.

As of September 29, 2025, Sr.Rayala.Hypo is considered undervalued with an attractive investment potential, supported by favorable valuation ratios like a PE of 9.85, and despite a YTD return of -28.19%, it stands out against peers like Solar Industries and Gujarat Fluoroch, indicating potential for recovery in the commodity chemicals industry.

As of September 25, 2025, Sr.Rayala.Hypo's technical trend is mildly bearish, driven by bearish MACD and Bollinger Bands on weekly charts, despite mixed signals from daily moving averages and OBV.